Home > Boards > Free Zone > Health and Sciences > Biotech Values

(ASMB)—ENTA’s CEO, Jay Luly just said that ASMB’s

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 751
Posts 115,697
Boards Moderated 12
Alias Born 09/05/02
160x600 placeholder
Top Company News of the Day
News Corp reported 3% revenue growth for the quarter that ended in March, driven by positive foreign-exchange fluctuations, plus solid growth at the company's digital real estate, book publishing and Dow Jones units.
Walmart Health To Acquire Telehealth Provider MeMD -- 4th Update
Gross Profit at Square Inc,'s Cash App More Than Doubled in the First Quarter
Walmart Health To Acquire Telehealth Provider MeMD -- 3rd Update
PayPal Wants More Customers to Pay Using Crypto Assets
Walmart Health To Acquire Telehealth Provider MeMD -- 2nd Update
Walmart Health To Acquire Telehealth Provider MeMD -- Update
Top Stories of the Day
Fed Says Covid is Major Financial Risk, Asset Prices Vulnerable to `Significant Declines'--Update
Square Raises 2021 Expense Guidance
Square Guides for Higher Transaction and Loan-Loss Expense in 2Q
Walmart Health To Acquire Telehealth Provider MeMD
Stocks Stage Late Rally; Dow Hits Record
Square's 1Q Revenue Soars on Bitcoin
Stocks Close Higher As Tech Shares Rebound, Dow Hits Record
Covid-19 Still Among Major Risks to Financial Stability, Fed Says
Soybeans Rise to New Highs as Weather Stays Dry
Cognizant Technology Solutions Down Nearly 9%, on Pace for Largest Percent Decrease in Over a Year -- Data Talk
Farm-District Democrats Raise Caution Flag on Capital-Gains Tax Plan
Stocks Turn Higher As Tech Shares Rebound
NBCUniversal Explores Streaming Its Sports Channels or Selling Them Off
195;rsted A/S Pge And Ørsted Have Closed The Joint Venture Agreement For Polish Offshore Wind Projects
DewDiligence Member Level  Tuesday, 05/07/19 05:08:33 PM
Re: DewDiligence post# 224682
Post # of 237978 
(ASMB)—ENTA’s CEO, Jay Luly just said that ASMB’s HBV core inhibitor is probably too weak, based on data presented at EASL (in so many words).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences